These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32911349)

  • 21. Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses.
    Jakobsen KD; Frederiksen JN; Parnas J; Werge T
    Psychopathology; 2006; 39(6):269-76. PubMed ID: 16960465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What is the optimal neuropsychological test battery for schizophrenia in China?
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2019 Jun; 208():317-323. PubMed ID: 30718121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis.
    Fusar-Poli P; Cappucciati M; Rutigliano G; Heslin M; Stahl D; Brittenden Z; Caverzasi E; McGuire P; Carpenter WT
    Schizophr Bull; 2016 Nov; 42(6):1395-1406. PubMed ID: 26980142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for cognitive deficits with the Evaluation of Cognitive Processes involved in Disability in Schizophrenia scale.
    Roux P; Urbach M; Fonteneau S; Berna F; Brunel L; Capdevielle D; Chereau I; Dubreucq J; Faget-Agius C; Fond G; Leignier S; Perier CC; Richieri R; Schneider P; Schürhoff F; Tronche AM; Yazbek H; Zinetti-Bertschy A; ; Passerieux C; Brunet-Gouet E
    Clin Rehabil; 2019 Jan; 33(1):113-119. PubMed ID: 30012064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties.
    Jędrasik-Styła M; Ciołkiewicz A; Styła R; Linke M; Parnowska D; Gruszka A; Denisiuk M; Jarema M; Green MF; Wichniak A
    Psychiatr Q; 2015 Sep; 86(3):435-47. PubMed ID: 25601030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms.
    Randers L; Fagerlund B; Jepsen JRM; Nordholm D; Krakauer K; Hjorthøj C; Glenthøj B; Nordentoft M
    Psychiatry Res; 2020 Dec; 294():113498. PubMed ID: 33157481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive deficits in first-episode psychosis: a population-based study in São Paulo, Brazil.
    Ayres AM; Busatto GF; Menezes PR; Schaufelberger MS; Coutinho L; Murray RM; McGuire PK; Rushe T; Scazufca M
    Schizophr Res; 2007 Feb; 90(1-3):338-43. PubMed ID: 17123787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study.
    Fonseca AO; Berberian AA; de Meneses-Gaya C; Gadelha A; Vicente MO; Nuechterlein KH; Bressan RA; Lacerda ALT
    Schizophr Res; 2017 Jul; 185():148-153. PubMed ID: 28110814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.
    Salazar de Pablo G; Catalan A; Fusar-Poli P
    JAMA Psychiatry; 2020 Mar; 77(3):311-320. PubMed ID: 31746950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological functioning in early and chronic stages of schizophrenia and psychotic bipolar disorder.
    Menkes MW; Armstrong K; Blackford JU; Heckers S; Woodward ND
    Schizophr Res; 2019 Apr; 206():413-419. PubMed ID: 31104720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Experience of Cognitive Impairment in People with Psychosis.
    Wood H; Cupitt C; Lavender T
    Clin Psychol Psychother; 2015; 22(3):193-207. PubMed ID: 24281753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses.
    Murray V; McKee I; Miller PM; Young D; Muir WJ; Pelosi AJ; Blackwood DH
    Psychol Med; 2005 Apr; 35(4):499-510. PubMed ID: 15856720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of cigarette smoking with cognitive impairment in male patients with chronic schizophrenia.
    Wei S; Wang D; Wei G; Wang J; Zhou H; Xu H; Xia L; Tian Y; Dai Q; Zhu R; Wang W; Chen D; Xiu M; Wang L; Zhang XY
    Psychopharmacology (Berl); 2020 Nov; 237(11):3409-3416. PubMed ID: 32757027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand.
    Srisurapanont M; Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Jantamo P
    Drug Alcohol Depend; 2020 May; 210():107961. PubMed ID: 32302795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bayesian model comparison approach to test the specificity of visual integration impairment in schizophrenia or psychosis.
    Grove TB; Yao B; Mueller SA; McLaughlin M; Ellingrod VL; McInnis MG; Taylor SF; Deldin PJ; Tso IF
    Psychiatry Res; 2018 Jul; 265():271-278. PubMed ID: 29768190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis.
    Eisenacher S; Rausch F; Ainser F; Englisch S; Becker A; Mier D; Fenske S; Meyer-Lindenberg A; Kirsch P; Zink M
    Early Interv Psychiatry; 2018 Aug; 12(4):586-595. PubMed ID: 27169782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of neuropsychological effort test performance in schizophrenia.
    Morra LF; Gold JM; Sullivan SK; Strauss GP
    Schizophr Res; 2015 Mar; 162(1-3):205-10. PubMed ID: 25583248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Rodriguez-Toscano E; López G; Mayoral M; Lewis S; Lees J; Drake R; Arango C; Rapado-Castro M
    Schizophr Res; 2020 Feb; 216():347-356. PubMed ID: 31813804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.